▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #1694 by analyst upside · 2026-09-27
AXSM
Axsome Therapeutics, Inc.
Healthcare · Market Cap $10B · P/E 0x
ANALYST PRICE TARGET
+46.2%
implied upside to consensus target
Current Price $195.09
Consensus Target $285.22
Bull Target $380.0
Bear Target $246.0
Analysts Covering 22
ANALYST CONSENSUS - BUY
Strong Buy
3
Buy
18
Hold
1
Sell
0
52-Week Low $116.18
52-Week High $260.19
YTD Return +9.2%
FUNDAMENTALS
Market Cap $10B
P/E Ratio (TTM) N/A
Forward P/E 41.7x
EPS (TTM) $-3.75
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $777M
Profit Margin -24.7%
52-WEEK RANGE
52-Week Low $116.18
52-Week High $260.19
Current Price $195.09
Bear Target $246.0
Bull Target $380.0
● Now $195.09 ● Target $285.22
TRADING DATA
Avg Volume 698K
YTD Return +9.2%
Analyst Count 22
Consensus Buy
Upside to Target +46.2%
Last Updated 2026-09-27

ANALYST SUMMARY

Axsome Therapeutics, Inc. (AXSM) is currently trading at $195.09 with a Wall Street consensus price target of $285.22, implying potential upside of 46.2% over the next 12 months. 22 analysts currently cover AXSM, with a consensus rating of Buy - 95% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $380.0, while the most cautious has a target of $246.0.

AXSM operates in the Healthcare sector with a market capitalisation of $10B. The stock is up 9.2% year-to-date and is currently trading near the upper end of its 52-week range of $116.18 – $260.19.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

UHS +8.7%
Universal Health Services, Inc.
$11B · P/E 7.3x · Hold
DVA +23.2%
DaVita Inc.
$11B · P/E 15.1x · Hold
GMED +38.5%
Globus Medical, Inc.
$10B · P/E 19.1x · Buy
FMS +11.7%
Fresenius Medical Care AG
$12B · P/E 12.0x · Hold
SNN +22.2%
Smith & Nephew plc
$11B · P/E 18.3x · Hold

RECENT ANALYST CALLS

Upgrade/downgrade history for AXSM, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Morgan Stanley - Reiterated
Equal-Weight → Equal-Weight 2026-09-25 Building track record
Truist Securities - Reiterated
Buy → Buy 2026-09-23 Building track record
Piper Sandler reit
Overweight → Overweight 2026-09-18 14% win rate (7 calls)
HC Wainwright & Co. reit
Buy → Buy 2026-08-31 31% win rate (48 calls)
Mizuho - Reiterated
Outperform → Outperform 2026-08-12 Building track record
Morgan Stanley - Reiterated
Equal-Weight → Equal-Weight 2026-08-11 Building track record
RBC Capital - Reiterated
Outperform → Outperform 2026-08-11 Building track record
Guggenheim - Reiterated
Buy → Buy 2026-08-11 62% win rate (8 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
62
out of 100
Coverage depth
24/30
Consensus clarity
16/30
Vote unanimity
20/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →